John C. Reed - EVP, Innovative Medicine, R&D at Johnson & Johnson

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Innovative Medicine, R&D
Stock Symbol
JNJ on NYSE
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by John C. Reed since 4/23/2024

Holdings reported by John C. Reed for Johnson & Johnson

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Employee Stock Options (Right to Buy) 89.8K $8.98M $100.06 Feb 15, 2025 Direct Common Stock
Restricted Share Units 53.5K $8.68M $162.16 May 1, 2024 Direct Common Stock
Common Stock 15.5K $2.43M $156.15 Feb 18, 2025 Direct
Restricted Share Units 5.54K $865K $156.15 Feb 15, 2025 Direct Common Stock

Transactions reported by John C. Reed for Johnson & Johnson

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.